# (Bispecific) Antibodies in Cancer Patients

> **NCT05119257** · — · AVAILABLE · sponsor: **University Hospital Tuebingen**

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** Bispecific antibodies (bsAB)

## Key facts

- **NCT ID:** NCT05119257
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05119257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05119257, "(Bispecific) Antibodies in Cancer Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05119257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*